- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01580111
Effect of Blood Storage Age on the Resolution of Lactic Acidosis in Children With Severe Malarial Anemia at Mulago Hospital
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective of the study is to evaluate the effect of blood storage age on resolution of lactic acidosis in children with severe malarial anemia.
Methods:
Children aged 6 - 59 months admitted to ACU with Severe Malarial Anemia (Hb <5g/dl) and Lactic Acidosis (blood lactate >5 mmol /l), will be randomly assigned to receive either blood of shorter storage age (<10 days) or longer storage age (21 -35 days) by gravity infusion as is the routine practice. 37 patients will be enrolled in each study arm. Physiological measurements namely blood lactate, oxygen saturation, Hemoglobin, Blood pressure, respiratory rate and pulse rate will be taken at baseline, during and after transfusion. The two groups will be compared. The primary outcome variable will be the proportion of children whose lactic acidosis resolves after 4 hrs of transfusion. 24hr mortality will be our secondary outcome.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kampala, Uganda, 256
- Mulago Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:Children aged 6 - 59 months admitted at Acute care Unit - Mulago hospital with;
- A positive B/S for malaria
- Severe anemia ( Hb ≤ 5 g/dl) and
- Lactic Acidosis (Blood lactate ≥ 5 mmol/l)
- Written informed consent from the caretaker.
Exclusion Criteria:
- Children undergoing transfusion with blood products other than packed cells.
- Children with known or concurrent cardiac disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Short storage
Short storage arm: Will receive blood (Packed red blood cells) of 1 (one) to 10 (ten) days in storage.
|
The short storage arm; children were transfused with packed red cells of storage age 1-10 days; while for the Long storage arm; were transfused with packed red cells of 21- 35 days in storage.
|
Active Comparator: Long storage arm
Will be transfused with blood ( packed red cells) of storage age 21- 35 days.
|
The short storage arm; children were transfused with packed red cells of storage age 1-10 days; while for the Long storage arm; were transfused with packed red cells of 21- 35 days in storage.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of blood storage age on the resolution of lactic acidosis in children with severe malarial anemia at Mulago hospital
Time Frame: 4hrs
|
The proportion of transfused patients who resolve lactic acidosis within 4 hours of transfusion
|
4hrs
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of blood storage age on the resolution of lactic acidosis in children with severe malarial anemia at Mulago hospital
Time Frame: 24 HRS
|
proportion of children who die within 24 hrs.
|
24 HRS
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: AGGREY DHABANGI, MBChB, M.Med, Makerere University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AD-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Compare Blood Age for Transfusion
-
Australian and New Zealand Intensive Care Research...University College Dublin; King Abdulaziz Medical City; Australian Red Cross; New... and other collaboratorsCompletedTransfusion | Age of BloodIreland, Australia, New Zealand, Finland, Saudi Arabia
-
Centre Hospitalier Universitaire de BesanconCentre Hospitalier Universitaire Dijon; Etablissement Français du SangCompletedErythrocyte Transfusion for All ConditionsFrance
-
Tel-Aviv Sourasky Medical CenterUnknownSmall for Gestational Age Infants | Appropriate for Gestational Age InfantsIsrael
-
Société des Produits Nestlé (SPN)CompletedSmall for Gestational Age (SGA) Infants | Appropriate for Gestational Age (AGA) InfantsIndia
-
CMC Ambroise ParéWithdrawnCompare Two Programming Modalities for CRT Devices in Heart Failure Patients With an Indication for Cardiac Resynchronization TherapyMonaco, France
-
SandozCompletedSmall for Gestational AgeBelgium, Czechia, Georgia, Hungary, Poland, Romania, Germany
-
PfizerCompletedSmall for Gestational Age
-
Dong-A ST Co., Ltd.CompletedInfant, Small for Gestational AgeKorea, Republic of
-
PfizerCompletedInfant, Small for Gestational AgeCzech Republic, Spain, Sweden, Netherlands, Belgium, France, Germany, Italy, Switzerland
-
GeneScience Pharmaceuticals Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsUnknownSmall for Gestational Age InfantChina
Clinical Trials on Blood transfusion
-
Hamad Medical CorporationSidra Medical and Research Center; World Anti-Doping Agency; Anti-Doping Lab... and other collaboratorsUnknownBlood Disease | Blood Transfusion, Autologous | Blood Doping | Blood Transfusion, HomologousQatar
-
Hospital PitangueirasUnknown
-
Emory UniversityWithdrawnHematopoietic and Lymphoid Cell Neoplasm | Leukemia | Anemia | Myelodysplastic Syndrome | Aplastic Anemia | Bone Marrow FailureUnited States
-
Haukeland University HospitalDentsply Sirona Implants and ConsumablesCompleted
-
Mahidol UniversityWolf Schleinzer Stiftung zur Wissenschafts- und Bildungsförderung, GermanyCompletedSurgery | Immune Defect | Incompatible Blood TransfusionThailand
-
Oregon Health and Science UniversityNot yet recruitingTraumatic Brain Injury
-
Assistance Publique - Hôpitaux de ParisCompletedMyocardial Infarction | Anemia | Blood TransfusionSpain, France
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Primary Myelofibrosis | Thrombocytopenia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Venous Thromboembolism | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Direction Centrale du Service de Santé des ArméesFloralis; TIMC-IMAGRecruitingTrauma | Coagulopathy | Acute HemorrhageFrance
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaboratorsRecruitingThe Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy VolunteersFrance